Consolidated Portfolio Review Corp Black Rock Health Sciences Trust Transaction History
Consolidated Portfolio Review Corp
- $429 Billion
- Q2 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 39,721 shares of BME stock, worth $1.68 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
39,721
Previous 16,992
133.76%
Holding current value
$1.68 Million
Previous $704 Million
130.44%
% of portfolio
0.38%
Previous 0.18%
Shares
5 transactions
Others Institutions Holding BME
# of Institutions
70Shares Held
3.17MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA448KShares$18.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY368KShares$15.5 Million0.0% of portfolio
-
Nova R Wealth, Inc.340KShares$14.4 Million7.46% of portfolio
-
1607 Capital Partners, LLC Richmond, VA228KShares$9.63 Million0.83% of portfolio
-
Invesco Ltd. Atlanta, GA201KShares$8.48 Million0.0% of portfolio
About BlackRock Health Sciences Trust
- Ticker BME
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...